FR2424031B1 - - Google Patents

Info

Publication number
FR2424031B1
FR2424031B1 FR7812053A FR7812053A FR2424031B1 FR 2424031 B1 FR2424031 B1 FR 2424031B1 FR 7812053 A FR7812053 A FR 7812053A FR 7812053 A FR7812053 A FR 7812053A FR 2424031 B1 FR2424031 B1 FR 2424031B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7812053A
Other languages
French (fr)
Other versions
FR2424031A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to FR7812053A priority Critical patent/FR2424031A1/en
Publication of FR2424031A1 publication Critical patent/FR2424031A1/en
Application granted granted Critical
Publication of FR2424031B1 publication Critical patent/FR2424031B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7812053A 1978-04-24 1978-04-24 Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5 Granted FR2424031A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7812053A FR2424031A1 (en) 1978-04-24 1978-04-24 Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7812053A FR2424031A1 (en) 1978-04-24 1978-04-24 Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5

Publications (2)

Publication Number Publication Date
FR2424031A1 FR2424031A1 (en) 1979-11-23
FR2424031B1 true FR2424031B1 (en) 1981-07-24

Family

ID=9207513

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7812053A Granted FR2424031A1 (en) 1978-04-24 1978-04-24 Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5

Country Status (1)

Country Link
FR (1) FR2424031A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
FR2505657A1 (en) * 1981-05-13 1982-11-19 Pasteur Institut IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
JPS63307827A (en) * 1987-06-08 1988-12-15 Kitasato Inst:The Stabilized live vaccine and production thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
FR1296510A (en) * 1958-05-09 1962-06-22 American Cyanamid Co Method of preparing an attenuated poliomyelitis virus

Also Published As

Publication number Publication date
FR2424031A1 (en) 1979-11-23

Similar Documents

Publication Publication Date Title
DE2954184A1 (en)
FR2413733B1 (en)
DE2820442C2 (en)
CH632116GA3 (en)
FR2414305B1 (en)
FR2424031B1 (en)
FR2414634B3 (en)
FR2414515B1 (en)
DE2815706C2 (en)
DK142444C (en)
BG25814A2 (en)
BG25957A1 (en)
BG26970A1 (en)
BG25952A1 (en)
BG26640A1 (en)
BG26022A1 (en)
BG26017A1 (en)
BG26015A1 (en)
BG26014A1 (en)
BG26013A1 (en)
BG26012A1 (en)
BG26009A1 (en)
BG26008A1 (en)
BG26007A1 (en)
BG26875A1 (en)